Semi-Annual Statement Of Changes In Equity

SymBio Pharmaceuticals Limited - Filing #7272884

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Semi-annual statement of changes in equity
Statement of changes in equity
Net assets
316,758,000 JPY
316,758,000 JPY
-89,863,000 JPY
-89,863,000 JPY
18,311,713,000 JPY
18,306,841,000 JPY
18,336,841,000 JPY
18,311,713,000 JPY
7,894,000 JPY
4,197,560,000 JPY
4,872,000 JPY
-32,794,671,000 JPY
3,764,020,000 JPY
-32,685,784,000 JPY
-32,794,671,000 JPY
4,080,779,000 JPY
18,336,841,000 JPY
3,872,907,000 JPY
7,894,000 JPY
277,044,000 JPY
277,044,000 JPY
17,952,692,000 JPY
-28,852,303,000 JPY
-28,871,032,000 JPY
6,920,120,000 JPY
17,922,692,000 JPY
17,927,584,000 JPY
-89,122,000 JPY
-28,871,032,000 JPY
-89,122,000 JPY
-5,985,000 JPY
7,209,909,000 JPY
4,891,000 JPY
17,952,692,000 JPY
6,938,849,000 JPY
-5,985,000 JPY
17,927,584,000 JPY
7,197,165,000 JPY
411,672,000 JPY
243,000 JPY
-88,154,000 JPY
243,000 JPY
8,506,092,000 JPY
-26,884,309,000 JPY
-88,154,000 JPY
17,548,459,000 JPY
17,548,459,000 JPY
-26,884,309,000 JPY
4,898,000 JPY
8,094,176,000 JPY
8,511,025,000 JPY
17,523,357,000 JPY
17,518,459,000 JPY
17,523,357,000 JPY
8,099,352,000 JPY
-26,889,486,000 JPY
411,672,000 JPY
Cumulative effects of changes in accounting policies
JPY
JPY
JPY
JPY
Restated balance
277,044,000 JPY
-28,871,032,000 JPY
6,920,120,000 JPY
17,922,692,000 JPY
17,927,584,000 JPY
-89,122,000 JPY
-28,871,032,000 JPY
4,891,000 JPY
17,952,692,000 JPY
7,197,165,000 JPY
-26,884,309,000 JPY
-88,154,000 JPY
17,548,459,000 JPY
-26,884,309,000 JPY
4,898,000 JPY
8,511,025,000 JPY
17,518,459,000 JPY
17,523,357,000 JPY
8,099,352,000 JPY
411,672,000 JPY
Changes during period
Issuance of new shares
364,425,000 JPY
728,850,000 JPY
364,425,000 JPY
728,850,000 JPY
728,850,000 JPY
728,850,000 JPY
364,425,000 JPY
364,425,000 JPY
364,425,000 JPY
692,400,000 JPY
692,400,000 JPY
346,200,000 JPY
346,200,000 JPY
346,200,000 JPY
692,400,000 JPY
346,200,000 JPY
692,400,000 JPY
346,200,000 JPY
Profit (loss)
-3,923,638,000 JPY
-3,923,638,000 JPY
-3,833,480,000 JPY
-3,923,638,000 JPY
-3,923,638,000 JPY
-1,962,817,000 JPY
-1,986,723,000 JPY
-1,986,723,000 JPY
-1,986,723,000 JPY
-1,986,723,000 JPY
Disposal of treasury shares
8,000 JPY
-19,000 JPY
28,000 JPY
28,000 JPY
-19,000 JPY
8,000 JPY
8,000 JPY
8,000 JPY
-19,000 JPY
21,000 JPY
-6,000 JPY
28,000 JPY
21,000 JPY
21,000 JPY
-6,000 JPY
21,000 JPY
28,000 JPY
-6,000 JPY
Net changes in items other than shareholders' equity
39,713,000 JPY
13,879,000 JPY
39,713,000 JPY
53,593,000 JPY
13,879,000 JPY
39,713,000 JPY
-134,627,000 JPY
-134,627,000 JPY
-6,228,000 JPY
-140,856,000 JPY
-6,228,000 JPY
-134,627,000 JPY
Total changes during period
39,713,000 JPY
384,149,000 JPY
-3,156,100,000 JPY
384,129,000 JPY
13,879,000 JPY
-740,000 JPY
-740,000 JPY
-19,000 JPY
-3,116,386,000 JPY
-3,012,348,000 JPY
-3,065,942,000 JPY
384,149,000 JPY
13,879,000 JPY
384,149,000 JPY
-3,833,480,000 JPY
-3,923,638,000 JPY
-3,923,638,000 JPY
384,129,000 JPY
39,713,000 JPY
-134,627,000 JPY
-134,627,000 JPY
-6,228,000 JPY
-1,296,183,000 JPY
-6,000 JPY
-1,986,723,000 JPY
-968,000 JPY
-6,228,000 JPY
-1,155,326,000 JPY
404,232,000 JPY
404,232,000 JPY
-1,986,723,000 JPY
404,232,000 JPY
-1,962,817,000 JPY
-1,179,232,000 JPY
404,226,000 JPY
-1,313,859,000 JPY
-968,000 JPY
404,226,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.